Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
2. Flomax
3. Ly 253352
4. Ly-253352
5. Tamsulosin
6. Ym 617
7. Ym-617
1. 106463-17-6
2. Flomax
3. Tamsulosin Hcl
4. Omnic
5. Pradif
6. Harnal
7. Urolosin
8. Secotex
9. Josir
10. Alna
11. Omic
12. Omix
13. Ym617
14. Ly253351
15. Amsulosin Hydrochloride
16. Tamsulosin (hydrochloride)
17. (r)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Hydrochloride
18. R-(-)-ym-12617
19. Ym 617
20. Ym-12617-1
21. Ym-617
22. Ly-253351
23. Chebi:9399
24. (-)-(r)-5-(2-((2-(o-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Monohydrochloride
25. 11sv1951mr
26. 5-[(2r)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride
27. 5-[(2r)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide;hydrochloride
28. 5-[(r)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]]-2-methoxybenzenesulfonamide Hydrochloride
29. R-(-)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Hydrochloride
30. Expros
31. Flomax (tn)
32. Dsstox_cid_26628
33. Dsstox_rid_81777
34. Dsstox_gsid_46628
35. 128332-25-2
36. Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, Monohydrochloride, (r)-
37. (r)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzenesulfonamide Hydrochloride
38. (-)-(r)-5-(2-((2-(o-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzene Sulfonamide Monohydrochloride
39. Cas-106463-17-6
40. Tamsulosine Hydrochloride
41. Ncgc00167442-01
42. Mfcd00922997
43. (r)-tamsulosin Hydrochloride
44. Unii-11sv1951mr
45. Tamsulosin.hcl
46. Harnalidge Ocas
47. Flomax Mr
48. Alnaocas
49. 5-[(2r)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide Hydrochloride
50. Flomax Hydrochloride
51. Harnal (tn)
52. Tamsulosin Hydrochloride [usan:usp:jan]
53. Tamsulosina Hydrochloride
54. Tamsulosinum Hydrochloride
55. (-)-ly 253352
56. Schembl23428
57. Tamsulosin Hydrochloride,(s)
58. Mls003899197
59. Racemic Tamsulosin Hydrochloride
60. Chembl1200914
61. Dtxsid2046628
62. Hy-b0661a
63. 5-[(2rs)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride (tamsulosin Racemate Hydrochloride)
64. Tox21_112446
65. Eu-617
66. S4729
67. (r)-tamsulosin Hydrochloride- Bio-x
68. Tamsulosin Hydrochloride (jp17/usp)
69. Tamsulosin Hydrochloride [jan]
70. Akos015895342
71. Akos015995287
72. Tox21_112446_1
73. Bs-1019
74. Ccg-269178
75. Tamsulosin Hydrochloride [usan]
76. (-)-ly253352
77. Tamsulosin Hydrochloride [mart.]
78. Tamsulosin Hydrochloride [vandf]
79. Ncgc00167442-03
80. Tamsulosin Hydrochloride [usp-rs]
81. Tamsulosin Hydrochloride [who-dd]
82. Bt164440
83. Smr002543366
84. Bcp0726000042
85. Tamsulosin Hydrochloride, >=98% (hplc)
86. T2749
87. Y-617
88. Tamsulosin Hydrochloride [orange Book]
89. A14936
90. D01024
91. Jalyn Component Tamsulosin Hydrochloride
92. Tamsulosin Hydrochloride [ep Monograph]
93. Tamsulosin Hydrochloride [usp Impurity]
94. Tamsulosin Hydrochloride [usp Monograph]
95. 463t176
96. A801444
97. Tamsulosin Hydrochloride Component Of Jalyn
98. Q-201777
99. (r)-(-)-ym12617;ly253351
100. (r)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2
101. Q27108379
102. Tamsulosin Hydrochloride, British Pharmacopoeia (bp) Reference Standard
103. Tamsulosin Hydrochloride, European Pharmacopoeia (ep) Reference Standard
104. (r)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Hcl
105. 5-((2r)-2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzene-sulfonamide Hcl
106. 5-[(r)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]]-2-methoxybenzenesulfonamidehydrochloride
107. Tamsulosin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
108. Tamsulosin Hydrochloride, United States Pharmacopeia (usp) Reference Standard
109. (r)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Monohydrochloride
110. 5-[(2r)-2-[[2-(-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride;tamsulosin Hcl
| Molecular Weight | 445.0 g/mol |
|---|---|
| Molecular Formula | C20H29ClN2O5S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 11 |
| Exact Mass | 444.1485709 g/mol |
| Monoisotopic Mass | 444.1485709 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 539 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Flomax |
| PubMed Health | Tamsulosin (By mouth) |
| Drug Classes | Benign Prostatic Hypertrophy Agent |
| Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
| Active Ingredient | Tamsulosin hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 0.4mg |
| Market Status | Prescription |
| Company | Boehringer Ingelheim |
| 2 of 4 | |
|---|---|
| Drug Name | Tamsulosin hydrochloride |
| Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
| Active Ingredient | Tamsulosin hydrochloride |
| Dosage Form | Capsule |
| Route | oral; Oral |
| Strength | 0.4mg |
| Market Status | Tentative Approval; Prescription |
| Company | Synthon Pharms; Anchen Pharms; Wockhardt; Ranbaxy; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Teva Pharms; Zydus Pharms Usa; Mylan; Impax Labs |
| 3 of 4 | |
|---|---|
| Drug Name | Flomax |
| PubMed Health | Tamsulosin (By mouth) |
| Drug Classes | Benign Prostatic Hypertrophy Agent |
| Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
| Active Ingredient | Tamsulosin hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 0.4mg |
| Market Status | Prescription |
| Company | Boehringer Ingelheim |
| 4 of 4 | |
|---|---|
| Drug Name | Tamsulosin hydrochloride |
| Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
| Active Ingredient | Tamsulosin hydrochloride |
| Dosage Form | Capsule |
| Route | oral; Oral |
| Strength | 0.4mg |
| Market Status | Tentative Approval; Prescription |
| Company | Synthon Pharms; Anchen Pharms; Wockhardt; Ranbaxy; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Teva Pharms; Zydus Pharms Usa; Mylan; Impax Labs |
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Adrenergic alpha-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)
API SUPPLIERS
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
Click Us!
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36934
Submission : 2022-03-30
Status : Active
Type : II
Certificate Number : CEP 2022-133 - Rev 02
Issue Date : 2025-07-29
Type : Chemical
Substance Number : 2131
Status : Valid
Date of Issue : 2025-09-24
Valid Till : 2028-07-07
Written Confirmation Number : WC-0165
Address of the Firm :
NDC Package Code : 52119-024
Start Marketing Date : 2024-01-05
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2023-09-21
Registration Number : 20230921-209-J-1512
Manufacturer Name : Swati Spentose Private Limited (Unit-I)
Manufacturer Address : Plot No. A-1/2102 & 2103 & A-2/2120, Phase III, GIDC, Vapi - 396 195 Dist : Valsad, Gujarat State India
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
With Fermion, start the journey of your innovative API.
✕ Product Not Available For Sales
Registration Number : 219MF10365
Registrant's Address : Koivu-Mankkaan tie 6A, FI-02200 Espoo, Finland
Initial Date of Registration : 2007-12-13
Latest Date of Registration :
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Temad- We think of world-class quality.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-12-23
Pay. Date : 2015-08-27
DMF Number : 28648
Submission : 2014-09-15
Status : Active
Type : II
Certificate Number : CEP 2012-309 - Rev 03
Issue Date : 2025-11-05
Type : Chemical
Substance Number : 2131
Status : Valid
Date of Issue : 2025-07-24
Valid Till : 2028-07-21
Written Confirmation Number : WC-0150N
Address of the Firm :
NDC Package Code : 17511-118
Start Marketing Date : 2020-01-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
| Available Reg Filing : CN, BR, TDMF, SA, KE |
DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
Jai Radhe Sales is your partner for all your sourcing needs.
HRV Pharma - Market Expansion Leader in Pharmaceuticals.
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
Certificate Number : CEP 2022-133 - Rev 02
Status : Valid
Issue Date : 2025-07-29
Type : Chemical
Substance Number : 2131
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : CEP 2012-309 - Rev 03
Status : Valid
Issue Date : 2025-11-05
Type : Chemical
Substance Number : 2131
Certificate Number : R1-CEP 2008-297 - Rev 01
Status : Valid
Issue Date : 2018-03-07
Type : Chemical
Substance Number : 2131
Tamsulosin Hydrochloride, A Code
Certificate Number : R1-CEP 2007-131 - Rev 02
Status : Valid
Issue Date : 2018-10-15
Type : Chemical
Substance Number : 2131
Tamsulosin Hydrochloride, C Code
Certificate Number : R1-CEP 2007-137 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2014-10-09
Type : Chemical
Substance Number : 2131
Certificate Number : R1-CEP 2008-206 - Rev 00
Status : Valid
Issue Date : 2015-06-10
Type : Chemical
Substance Number : 2131
Certificate Number : R1-CEP 2007-014 - Rev 05
Status : Valid
Issue Date : 2020-05-15
Type : Chemical
Substance Number : 2131
Certificate Number : R1-CEP 2010-204 - Rev 01
Status : Valid
Issue Date : 2016-10-25
Type : Chemical
Substance Number : 2131
Certificate Number : R1-CEP 2007-234 - Rev 00
Status : Valid
Issue Date : 2014-03-07
Type : Chemical
Substance Number : 2131
Certificate Number : R1-CEP 2009-121 - Rev 02
Status : Valid
Issue Date : 2021-12-14
Type : Chemical
Substance Number : 2131
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] JDMF
With Fermion, start the journey of your innovative API.
Registration Number : 219MF10365
Registrant's Address : Koivu-Mankkaan tie 6A, FI-02200 Espoo, Finland
Initial Date of Registration : 2007-12-13
Latest Date of Registration : 2021-05-27
Registration Number : 226MF10100
Registrant's Address : 136, Changgyeonggung-ro, Jongno-gu, Seoul, Korea
Initial Date of Registration : 2014-05-14
Latest Date of Registration : 2014-05-14
Registration Number : 230MF10019
Registrant's Address : 78, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea
Initial Date of Registration : 2018-02-05
Latest Date of Registration : 2018-02-05
Japanese Pharmacopoeia Tamsulosin Hydrochloride
Registration Number : 222MF10174
Registrant's Address : 1-4-29 Shibashima, Higashiyodogawa-ku, Osaka City, Osaka Prefecture
Initial Date of Registration : 2010-06-18
Latest Date of Registration : 2010-06-18
Tamsulosin Hydrochloride "Hamari"
Registration Number : 217MF11145
Registrant's Address : 1-4-29 Shibashima, Higashiyodogawa-ku, Osaka City, Osaka Prefecture
Initial Date of Registration : 2005-12-05
Latest Date of Registration : 2006-09-22
Japanese Pharmacopoeia Tamsulosin Hydrochloride "Hamari"
Registration Number : 219MF10139
Registrant's Address : 1-4-29 Shibashima, Higashiyodogawa-ku, Osaka City, Osaka Prefecture
Initial Date of Registration : 2007-04-18
Latest Date of Registration : 2007-04-18
Tamsulosin Hydrochloride (Japanese Pharmacopoeia)
Registration Number : 230MF10156
Registrant's Address : 1-19-40 Nanko Kita, Suminoe-ku, Osaka City, Osaka Prefecture
Initial Date of Registration : 2018-11-14
Latest Date of Registration : 2022-05-25
Japanese Pharmacopoeia Tamsulosin Hydrochloride (For manufacturing purposes only)
Registration Number : 221MF10247
Registrant's Address : 207, Sujeong-ro, Jangan-myeon, Hwaseong-si, Gyeonggi-do, 18581, Republic of Korea
Initial Date of Registration : 2009-11-17
Latest Date of Registration : 2016-02-24
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
Tamsulosin Hydrochloride BP/IP/EP/USP
Date of Issue : 2025-09-24
Valid Till : 2028-07-07
Written Confirmation Number : WC-0165
Address of the Firm : Plot No. A-1/2102 & 2103, Phase-III, G.I.D.C Vapi-396195, Valsad, Gujarat, India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Tamsulosin Hydrochloride IP/USP/Ph. Eur
Date of Issue : 2025-07-24
Valid Till : 2028-07-21
Written Confirmation Number : WC-0150N
Address of the Firm : API Unit-l, R.S. No. 50/1, Mukteswarapuram Village,\r\nJaggaiahpet Mandal, NTR D...
Tamsulosin Hydrochloride Ph. Eur
Date of Issue : 2025-08-08
Valid Till : 2028-06-10
Written Confirmation Number : WC-0017
Address of the Firm : Unit-II, SurveyNo.:10&13,Gaddapotharam (Village), IDA-Kazipally, Jinnaram (Manda...
Tamsulosin Hydrochloride USP/Ph.Eur./BP
Date of Issue : 2025-06-13
Valid Till : 2028-06-16
Written Confirmation Number : WC-0031
Address of the Firm : Unit-l, Lingojigudem Village, Choutuppal Mandal, Yadadri Bhuvanagiri District
Tamsulosin Hydrochloride USP/BP/EP
Date of Issue : 2025-08-08
Valid Till : 2028-07-25
Written Confirmation Number : WC-0027
Address of the Firm : Unit-ll, Sy. No. 14, Gaddapotharam Village, IDA, Khazipally, Jinnaram Mandal, Sa...
Tamsulosin Hydrochloride USP/Ph. Eur.
Date of Issue : 2025-08-05
Valid Till : 2028-06-02
Written Confirmation Number : WC-0011
Address of the Firm : Village Toansa, P.O. Rail Majra, Tehsil Balachaur, District S.B.S. Nagar (Punjab...
Tamsulosin Hydrochloride USP/Ph.Eur
Date of Issue : 2022-08-16
Valid Till : 2025-07-15
Written Confirmation Number : WC-0042N
Address of the Firm : Plot Nos. 262 to 271, IDA, Pashamylaram, Sangareddy District- 502 307, Telangana...
Tamsulosin Hydrochloride Ph.Eur
Date of Issue : 2022-06-30
Valid Till : 2025-07-28
Written Confirmation Number : WC-0063
Address of the Firm : Plot No. 99, MIDC Area - Dhatav Roha, Dist. Raigad, Roha, Raigad-402116, Maharas...
Tamsulosin Hydrochloride BP/USP/Ph.Eur.
Date of Issue : 2025-08-01
Valid Till : 2028-07-14
Written Confirmation Number : WC-0183
Address of the Firm : Unit -Il, Plot No.79, Jawaharlal Nehru Pharma City, Thanam (V), Parawada (M), An...
Tamsulosin Hydrochloride USP/EP
Date of Issue : 2025-10-07
Valid Till : 2028-07-02
Written Confirmation Number : WC-0075
Address of the Firm : Plot No. 138, G.I.D.C., Ankleshwar, Dist: Bharuch-393 002, Gujarat, INDIA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2023-09-21
Registration Number : 20230921-209-J-1512
Manufacturer Name : Swati Spentose Private Limit...
Manufacturer Address : Plot No. A-1/2102 & 2103 & A-2/2120, Phase III, GIDC, Vapi - 396 195 Dist : Valsad, G...
Registrant Name : Astellas Pharma Korea Co., Ltd.
Registration Date : 2023-07-06
Registration Number : 20230706-209-J-1474
Manufacturer Name : Astellas Ireland Co. Limited
Manufacturer Address : Damastown Road, Damastown Industrial Park, Dublin 15, D15 K851, Ireland
Registrant Name : Innovent
Registration Date : 2025-09-26
Registration Number : 20250926-209-J-2012
Manufacturer Name : Changzhou Ruiming Pharmaceut...
Manufacturer Address : No.1558 Longjiang Bei Road, Chunjiang Towm, Xinbei District, Changzhou City, 213127, ...
Registrant Name : Yuil Pharmtech Co., Ltd.
Registration Date : 2025-04-18
Registration Number : 20210405-209-J-767(2)
Manufacturer Name : Curia Spain SAU
Manufacturer Address : Parque Tecnológico Boecillo Parcela 2 y 3 Boecillo 47151, Valladolid, Spain
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2025-03-11
Registration Number : 20250311-209-J-1806
Manufacturer Name : Nosch Labs Pvt Ltd@Nosch Lab...
Manufacturer Address : 5-5-35/33/3, Prashanthi Nagar, Kukatpally(Village & Mandal), Medchal - Malkajgiri Dis...
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2025-03-26
Registration Number : 20250311-209-J-1806(1)
Manufacturer Name : Nosch Labs Pvt Ltd@Nosch Lab...
Manufacturer Address : 5-5-35/33/3, Prashanthi Nagar, Kukatpally(Village & Mandal), Medchal - Malkajgiri Dis...
Registrant Name : Essel Bio Co., Ltd.
Registration Date : 2025-01-13
Registration Number : 20250113-209-J-1645
Manufacturer Name : Pellets Pharma Limited@Zydus...
Manufacturer Address : Plot No.: 8&9, EPIP-TSIIC, Pashamylaram, Pashamylaram Village, Patancheru Mandal, San...
Registrant Name : Sangjin Trading Co., Ltd.
Registration Date : 2025-01-10
Registration Number : 20190808-209-J-234(A)
Manufacturer Name : Suven Pharmaceuticals Limite...
Manufacturer Address : Plot No's. 262 to 271, IDA, Pashamylaram Village, Patancheru Mandal, Sangareddy Distr...
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2024-04-09
Registration Number : 20200908-209-J-468(A)
Manufacturer Name : Synthon, sro
Manufacturer Address : Brenenska 32/cp. 597, 678 01 Blansko, Czech Republic
Registrant Name : Pamirae Co., Ltd.
Registration Date : 2025-01-14
Registration Number : 20250114-209-J-1646
Manufacturer Name : Zhejiang Jinhua Conba BIO-Ph...
Manufacturer Address : No. 333, Wuxi Road, Tangxi Town, Jinhua City, Zhejiang Province, China
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
NDC Package Code : 52119-024
Start Marketing Date : 2024-01-05
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-118
Start Marketing Date : 2020-01-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12838-2788
Start Marketing Date : 2010-07-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-298
Start Marketing Date : 2024-01-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-024
Start Marketing Date : 2004-04-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53296-0073
Start Marketing Date : 2010-05-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (75kg/75kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53069-0860
Start Marketing Date : 2003-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-2074
Start Marketing Date : 2004-01-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68022-7005
Start Marketing Date : 2016-02-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 53747-018
Start Marketing Date : 2010-12-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
About the Company : Swati Spentose Pvt. Ltd. (SSPL), part of the 60-year-old V Group, is a globally trusted pharmaceutical manufacturer supplying to 70+ countries. We specialize in high-quality APIs a...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
Temad- We think of world-class quality.
About the Company : Established in 1997, Temad Co. is one of the largest producers of APIs in Iran & an innovative manufacturer of narcotic and non-narcotic products of world-class quality in the Midd...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...
DKSH is your trusted partner for companies looking to grow their business in Asia & beyond.
About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering g...
Jai Radhe Sales is your partner for all your sourcing needs.
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
HRV Pharma - Market Expansion Leader in Pharmaceuticals.
About the Company : HRV Pharma is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
About the Company : Octavius Pharma is a global leader in Directly Compressible Granules with over 45 years of expertise in formulation development, manufacturing, and commercialization. Our portfolio...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
Details:
Tamsulosin is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Urinary Retention.
Lead Product(s): Tamsulosin,Inapplicable
Therapeutic Area: Urology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 15, 2025
Lead Product(s) : Tamsulosin,Inapplicable
Therapeutic Area : Urology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Tamsulosin is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Urinary Retention.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 15, 2025
Details:
Tamsulosin is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Tamsulosin,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 05, 2025
Lead Product(s) : Tamsulosin,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Tamsulosin is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 05, 2025
Details:
Tamsulosin is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of unspecified medical condition.
Lead Product(s): Tamsulosin,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 28, 2025
Lead Product(s) : Tamsulosin,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Tamsulosin 0.4 mg PR vs Omnic Ocas® Steady-State Bioavailability In Healthy Male Adults
Details : Tamsulosin is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of unspecified medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 28, 2025
Details:
Tamsulosin is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of unspecified medical condition.
Lead Product(s): Tamsulosin,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 29, 2025
Lead Product(s) : Tamsulosin,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Tamsulosin 0.4 mg PR vs Omnic Ocas® Fed-State Bioavailability In Healthy Male Adults
Details : Tamsulosin is a Other Small Molecule drug candidate, which is currently being evaluated in Phase I clinical studies for the treatment of unspecified medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 29, 2025
Details:
Tamsulosin is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Lead Product(s): Tamsulosin,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 25, 2025
Lead Product(s) : Tamsulosin,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
Details : Tamsulosin is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 25, 2025
Details:
Bovhyaluronidase Azoximer is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Lower Urinary Tract Symptoms.
Lead Product(s): Bovhyaluronidase Azoximer,Tamsulosin
Therapeutic Area: Urology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Undisclosed
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 23, 2024
Lead Product(s) : Bovhyaluronidase Azoximer,Tamsulosin
Therapeutic Area : Urology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Bovhyaluronidase Azoximer is a drug candidate, which is currently being evaluated in clinical studies for the treatment of Lower Urinary Tract Symptoms.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
August 23, 2024
Details:
Tamsulosin is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Tamsulosin,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 16, 2024
Lead Product(s) : Tamsulosin,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Tamsulosin 0.4 mg Sustained Release Film-coated Tablets
Details : Tamsulosin is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 16, 2024
Details:
DCGI has approved Tamsulosin (selective alpha1A-adrenergic receptor antagonist) + Tadalafil, a fixed dose combination within a hard gelatin capsule for the treatment of erectile dysfunction & benign prostatic hyperplasia.
Lead Product(s): Tamsulosin,Tadalafil
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 15, 2023
Lead Product(s) : Tamsulosin,Tadalafil
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Akums Introduces Tamsulosin + Tadalafil Capsule — to the Indian Market
Details : DCGI has approved Tamsulosin (selective alpha1A-adrenergic receptor antagonist) + Tadalafil, a fixed dose combination within a hard gelatin capsule for the treatment of erectile dysfunction & benign prostatic hyperplasia.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 15, 2023
Details:
Tamsulosin is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Ureteral Calculi.
Lead Product(s): Tamsulosin,Inapplicable
Therapeutic Area: Urology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 04, 2023
Lead Product(s) : Tamsulosin,Inapplicable
Therapeutic Area : Urology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Medical Stone Expulsive Therapy for Acutely Obstructed Ureteric Calculi
Details : Tamsulosin is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Ureteral Calculi.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 04, 2023
Details:
Solifenacin Succinate is a muscarinic receptor antagonist and tamsulosin is an alpha-1A and alpha-1B adrenergic receptor antagonist used in combination to treat benign prostatic hyperplasia.
Lead Product(s): Solifenacin Succinate,Tamsulosin
Therapeutic Area: Urology Brand Name: Vesomni-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Adamed Pharma
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 23, 2023
Lead Product(s) : Solifenacin Succinate,Tamsulosin
Therapeutic Area : Urology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Adamed Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Adalvo and Adamed Pharma Team up to Launch Solifenacin + Tamsulosin in Europe
Details : Solifenacin Succinate is a muscarinic receptor antagonist and tamsulosin is an alpha-1A and alpha-1B adrenergic receptor antagonist used in combination to treat benign prostatic hyperplasia.
Product Name : Vesomni-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 23, 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
Rampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.
(R)-5-(2-Aminopropyl)-2-Methoxy benzenesulfonamide
CAS Number : 112101-81-2
End Use API : Tamsulosin
About The Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hydera...
Rampex Labs – Simplifying Synthesis with Innovation, Quality, and Commitment to Global Pharmaceutical Excellence.
2-(2- Ethoxy Phenoxy) Ethyl Bromide
CAS Number : 3259-03-8
End Use API : Tamsulosin
About The Company : Rampex Labs, founded in 2004, is a fully cGMP-compliant pharmaceutical manufacturer with two USFDA-approved facilities in Hyderabad and Vizag, India. The Hydera...
R-(-)-5-(2-Amino-propyl)-2-methoxy-benzenesulfonam...
CAS Number : 112101-81-2
End Use API : Tamsulosin
About The Company : Anvitha Life Care Private Limited, founded in 2016 by Dr. T. Prakasam and a team of experienced scientists and technocrats with over 80 years of combined expert...
(R)-5-(2-Aminopropyl)-2-methoxybenzenesulfonamide
CAS Number :
End Use API : Tamsulosin
About The Company : Chr. Olesen Synthesis is a Danish manufacturer of APIs and advanced intermediates. Chr. Olesen Synthesis was established in 2012 after the Chr. Olesen Group acq...
R-(-)-5-(2-Amino-propyl)-2-methoxy-benzenesulfonam...
CAS Number : 112101-81-2
End Use API : Tamsulosin
About The Company : LUNA Chemicals Co.,Ltd. markets and manufactures world-class quality Active Pharmaceutical Ingredients and intermediate chemicals for generic pharmaceutical com...
1 (2-Bromoethoxy)-2 -Ethoxybenzene
CAS Number : 3259-03-8
End Use API : Tamsulosin
About The Company : Neochem Pharma LLP, established in 2020 by Dr. Madhavi Patel, is a Morbi-based developer, manufacturer, exporter, and supplier of specialized pharmaceutical pow...
2-Methoxy-5-(2-oxopropyl)benzenesulfonamide
CAS Number : 116091-63-5
End Use API : Tamsulosin
About The Company : Neochem Pharma LLP, established in 2020 by Dr. Madhavi Patel, is a Morbi-based developer, manufacturer, exporter, and supplier of specialized pharmaceutical pow...
2-(2-Ethoxyphenoxy)ethyl Methanesulfonate
CAS Number : 169506-15-4
End Use API : Tamsulosin
About The Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and developmen...
2-(2-Ethoxyphenoxy)ethyl bromide
CAS Number : 3259-03-8
End Use API : Tamsulosin
About The Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and developmen...
R-(-)-5-(2-Amino-propyl)-2-methoxy-benzenesulfonam...
CAS Number : 112101-81-2
End Use API : Tamsulosin
About The Company : Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and developmen...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CAPSULE;ORAL - 0.4MG
USFDA APPLICATION NUMBER - 20579
DOSAGE - CAPSULE;ORAL - 0.5MG;0.4MG
USFDA APPLICATION NUMBER - 22460
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CD Formulation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Doshion Polyscience
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Huzhou Sunflower Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Coating Systems & Additives
Fillers, Diluents & Binders
Controlled & Modified Release
Thickeners and Stabilizers
Solubilizers
Film Formers & Plasticizers
Topical
Taste Masking
Direct Compression
Lubricants & Glidants
Granulation
Parenteral
Co-Processed Excipients
Emulsifying Agents
Empty Capsules
Rheology Modifiers
Disintegrants & Superdisintegrants
Chewable & Orodispersible Aids
Coloring Agents
Surfactant & Foaming Agents
API Stability Enhancers
Vegetarian Capsules
Soft Gelatin
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
ABOUT THIS PAGE
18
PharmaCompass offers a list of Tamsulosin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tamsulosin manufacturer or Tamsulosin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tamsulosin manufacturer or Tamsulosin supplier.
PharmaCompass also assists you with knowing the Tamsulosin API Price utilized in the formulation of products. Tamsulosin API Price is not always fixed or binding as the Tamsulosin Price is obtained through a variety of data sources. The Tamsulosin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tamsulosin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tamsulosin Hydrochloride, including repackagers and relabelers. The FDA regulates Tamsulosin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tamsulosin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tamsulosin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tamsulosin Hydrochloride supplier is an individual or a company that provides Tamsulosin Hydrochloride active pharmaceutical ingredient (API) or Tamsulosin Hydrochloride finished formulations upon request. The Tamsulosin Hydrochloride suppliers may include Tamsulosin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Tamsulosin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tamsulosin Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Tamsulosin Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Tamsulosin Hydrochloride DMFs exist exist since differing nations have different regulations, such as Tamsulosin Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tamsulosin Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Tamsulosin Hydrochloride USDMF includes data on Tamsulosin Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tamsulosin Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tamsulosin Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tamsulosin Hydrochloride Drug Master File in Japan (Tamsulosin Hydrochloride JDMF) empowers Tamsulosin Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tamsulosin Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Tamsulosin Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tamsulosin Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Tamsulosin Hydrochloride Drug Master File in Korea (Tamsulosin Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tamsulosin Hydrochloride. The MFDS reviews the Tamsulosin Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Tamsulosin Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Tamsulosin Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tamsulosin Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Tamsulosin Hydrochloride suppliers with KDMF on PharmaCompass.
A Tamsulosin Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Tamsulosin Hydrochloride Certificate of Suitability (COS). The purpose of a Tamsulosin Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tamsulosin Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tamsulosin Hydrochloride to their clients by showing that a Tamsulosin Hydrochloride CEP has been issued for it. The manufacturer submits a Tamsulosin Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tamsulosin Hydrochloride CEP holder for the record. Additionally, the data presented in the Tamsulosin Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tamsulosin Hydrochloride DMF.
A Tamsulosin Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tamsulosin Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tamsulosin Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Tamsulosin Hydrochloride written confirmation (Tamsulosin Hydrochloride WC) is an official document issued by a regulatory agency to a Tamsulosin Hydrochloride manufacturer, verifying that the manufacturing facility of a Tamsulosin Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tamsulosin Hydrochloride APIs or Tamsulosin Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Tamsulosin Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Tamsulosin Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tamsulosin Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tamsulosin Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tamsulosin Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tamsulosin Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tamsulosin Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tamsulosin Hydrochloride suppliers with NDC on PharmaCompass.
Tamsulosin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tamsulosin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tamsulosin Hydrochloride GMP manufacturer or Tamsulosin Hydrochloride GMP API supplier for your needs.
A Tamsulosin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Tamsulosin Hydrochloride's compliance with Tamsulosin Hydrochloride specifications and serves as a tool for batch-level quality control.
Tamsulosin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Tamsulosin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tamsulosin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Tamsulosin Hydrochloride EP), Tamsulosin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tamsulosin Hydrochloride USP).
